Microbot Medical expands LIBERTY system manufacturing via Sanmina agreement to boost capacity, cut costs

Microbot Medical entered a Letter of Agreement with Sanmina to manufacture the LIBERTY Endovascular Robotic System, expanding capacity to meet rising demand.Key Highlights:Original SEC Filing: Microbot Medical Inc. [ MBOT ] - 8-K - Jun. 30, 2026This is an AI-powered summary. It may contain inaccura…

Microbot Medical entered a Letter of Agreement with Sanmina to manufacture the LIBERTY Endovascular Robotic System, expanding capacity to meet rising demand.

Key Highlights:

Signed LOA with Sanmina to manufacture the LIBERTY system, adding a second manufacturing site.
Move intended to expand capacity to meet increased U.S. and international demand and new accounts.
Agreement expected to improve operating efficiencies, lower costs and expand gross margins.
Sanmina’s global footprint supports scaling production as the company pursues CE Mark and other registrations.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.